2022-RA-1504-ESGO Tamoxifen-megestrol acetate combination hormonal therapy is an effective fertility-sparing treatment in early-stage endometrial cancer patients who have failed progestin only hormonal therapy

Authors :: Hyunji Lim
Seung Jun Lee
Seoyoon Lee
Maria Lee
Hee Seung Kim
Hyun Hoon Chung
Jae-Weon Kim
Yong-Sang Song
Noh Hyun Park
Source :: Endometrial cancer.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools